A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to schizophrenia treatment. The Food and Drug Administration approved it Thursday.

The promising drug combination was discovered and tested by Karuna Therapeutics, which Bristol Myers Squibb acquired in March. Bristol Myers Squibb will sell the drug combination under the brand name ...

Bristol Myers Squibb received U.S. Food and Drug Administration (FDA) approval on Thursday for its groundbreaking ...

Bristol-Myers Squibb's acquisition of Karuna and FDA approval of Cobenfy signal growth potential, with focus on driving ...

The treatment offers hope to thousands of patients who do not respond to existing medications, and has shown promise in treating other neurological disorders.

What comes next for Pfizer's Oxbryta sickle cell drug —Cassava Sciences' SEC charges —Bristol's new schizophrenia treatment ...

Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely ...

Roche's oral anti-obesity candidate outperformed a similar candidate from Viking Therapeutics in terms of efficacy. Viking Therapeutics' oral anti-obesity candidate appears much easier to tolerate ...

The funding aims at supporting further advancements on the Coventry-based firms technology platform to accelerate the development of biologic therapeutics. Funding was co-led by BGF, Octopus ...

Actress Karuna Pandey, known for her role in Pushpa Impossible, shares her journey from learning Bharatnatyam and Kathak to pursuing a degree in Performing Arts. Despite the pressures of social ...

Seven jobs will be cut at Coventry University following a review into its Centre for Peace and Security. The centre contributes to work on human security, peace studies and social relations ...

Teachers' Day celebrates educators' pivotal role in shaping futures. Artists recount how their teachers profoundly impacted their lives and careers. They highlight lessons of independence ...